Conclusions
In this study, we found no current evidence from blinded, placebo-controlled, RCT on the efficacy of nitazoxanide in treating patients with COVID-19. This living systematic review should be updated as soon as the results of ongoing RCT are published.
Key words: COVID-19; SARS-CoV-2 infection; nitazoxanide.